EVIAGENICS concluded in June 2015 the sale of its yeast based Vanillin technology (and related patents) to a large industrial player. The terms and conditions of this transaction are confidential. Algaia is now concentrating its Biotech R&D efforts to specific Flavonoids production.
EVIAGENICS sells its Vanillin technology
